
Feldman S, Zhang J, Martinez D, et al. Real-world treatment patterns of biologics, apremilast among patients with moderate to severe plaque psoriasis by metabolic syndrome status [abstract L11]. J Manag Care Spec Pharm. 2019, 25(suppl 10-a):S78. doi: 10.18553/jmcp.2019.25.10-a.s1.
Advertisement
Articles by Feldman S, Zhang J, Martinez D, et al. Real-world treatment patterns of biologics, apremilast among patients with moderate to severe plaque psoriasis by metabolic syndrome status [abstract L11]. J Manag Care Spec Pharm. 2019, 25(suppl 10-a):S78. doi: 10.18553/jmcp.2019.25.10-a.s1.

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First siRNA Therapy for AChR-Positive Myasthenia Gravis
2
Defining High-Efficacy MS Therapy: Access, Formularies, and Patient Choice
3
Health Equity & Access Weekly Roundup: November 20, 2026
4
Low CRC Incidence Found After Endoscopic Mucosal Resection
5